Atlas FDA

CYBERONICS VNS THERAPY SYSTEM

FDA premarket approval P970003/S181 · decided 2015-07-31

Approval details

PMA number
P970003
Supplement
S181
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
CYBERONICS VNS THERAPY SYSTEM
Generic name
Stimulator, autonomic nerve, implanted (depression)
Applicant
LivaNova USA, Inc.
Date received
2015-06-22
Decision date
2015-07-31
Days to decision
39 days
Decision code
OK30
Product code
MUZ
Advisory committee
Neurology
Expedited review
No
Location
Houston, TX
Statement
USE OF NEW PROCESSES FOR REPROCESSING TABLET COMPUTERS RETURNED FROM THE FIELD AND A PROCESS TO INSTALL PREVIOUSLY APPROVED SOFTWARE UPGRADES ON TABLET COMPUTERS THAT HAVE BEEN DISTRIBUTED TO THE FIELD FOR THE CYBERONICS® VNS THERAPY® SYSTEM TABLET COMPUTERS (MOTION MODEL CL900 OR CYBERONICS MODEL 700, MOTION MODEL CL910 OR CYBERONICS MODEL 720).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Venous Return Cannulae (K250937)LivaNova USA, Inc.2026-03-11
RAP Femoral Venous Cannulae (K250283)LivaNova USA, Inc.2025-07-10
SMARxT Tubing and Connectors (K233702)LivaNova USA, Inc.2024-08-08